- Integral Diagnostics Ltd Annual Shareholders Meeting TranscriptNov 28, 2023
- Full Year 2023 Integral Diagnostics Ltd Earnings Call TranscriptAug 28, 2023A$3.11 (-0.32%)Earnings
- Half Year 2023 Integral Diagnostics Ltd Earnings Call TranscriptFeb 17, 2023A$2.67 (-14.97%)Earnings
- Integral Diagnostics Ltd Annual Shareholders Meeting TranscriptNov 03, 2022
- Full Year 2022 Integral Diagnostics Ltd Earnings Call TranscriptAug 29, 2022A$2.91 (-7.03%)Earnings
- Half Year 2022 Integral Diagnostics Ltd Earnings Call TranscriptFeb 22, 2022A$3.86 (-0.51%)Earnings
- Integral Diagnostics Ltd Annual Shareholders Meeting TranscriptNov 04, 2021
- Full Year 2021 Integral Diagnostics Ltd Earnings Call TranscriptAug 27, 2021A$4.52 (-15.19%)Earnings
- Half Year 2021 Integral Diagnostics Ltd Earnings Call TranscriptFeb 21, 2021Earnings
- Integral Diagnostics Ltd Annual Shareholders Meeting TranscriptOct 29, 2020
- Full Year 2020 Integral Diagnostics Ltd Earnings Call TranscriptAug 25, 2020A$4.02 (+4.08%)Earnings
- Half Year 2020 Integral Diagnostics Ltd Earnings Call TranscriptFeb 19, 2020A$3.9 (-2.71%)Earnings
- Full Year 2019 Integral Diagnostics Ltd Earnings Call TranscriptAug 26, 2019Earnings
Half Year 2023 Integral Diagnostics Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the Integral Diagnostics, IDX, Half Year Results 2023. (Operator Instructions).
I would now like to hand the conference over to Dr. Ian Kadish, CEO and MD. Please go ahead.
Thank you very much, Tashi. My name is Ian Kadish. I am the Managing Director and Chief Executive Officer of Integral Diagnostics. I'm joined here this morning by Craig White, who is our Chief Financial Officer. Thank you all for joining our results call this morning.
You may have noted that we brought the call forward because we were ready, we had had a clean half year, and we have completed our auditor review. From a consensus perspective, you'll see that we were slightly above for revenue, we were in line for EBITDA, and we were divergent below the operating earnings line at EBIT and NPAT. We've also called out, you'll note in the presentation, a revenue improvement in quarter 2 over quarter 1 and double-digit improvement over January last year.
Turning
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)